Wang J, Li B, Zhang Y, Luo X, et al. Tislelizumab combined with nab-paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two-cohort, phase 2 trial. Int J Cancer 2024 Dec 16. doi: 10.1002/ijc.35261.
PMID: 39686540